Bone Biologics Corp (BBLGW) EPS (Basic) (2010 - 2025)
Bone Biologics (BBLGW) posted quarterly EPS (Basic) of -$0.58 for Q4 2025, up 90.32% year-over-year from -$0.31 in Q4 2024, and down 56.89% quarter-over-quarter from -$0.37 in Q3 2025.
Bone Biologics Corp (BBLGW) EPS (Basic) (2010 - 2025) Analysis & Trends
Bone Biologics (BBLGW) has reported EPS (Basic) for 16 consecutive years, with -$0.58 the latest figure, recorded in Q4 2025.
- In Q4 2025, EPS (Basic) rose 90.32% year-over-year to -$0.58; the TTM figure through Dec 2025 stood at -$2.65 (up 90.92% YoY), while the FY2025 annual figure was -$2.65, up 90.86% from the prior year.
- EPS (Basic) retreated to -$0.58 in Q4 2025 per BBLGW's latest filing, from -$0.37 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.37 in Q3 2025 and bottomed at -$2728.1 in Q4 2022.
- Historically, EPS (Basic) has averaged -$217.06 across 5 years, with a median of -$45.59 in 2023.
- Annual changes were most pronounced in 2022 — EPS (Basic) slumped 4785.03% — and 2023, when it jumped 98.7%.
- Bone Biologics' EPS (Basic) stood at -$55.85 in 2021, then plunged by 4785.03% to -$2728.1 in 2022, then surged by 98.7% to -$35.34 in 2023, then jumped by 82.97% to -$6.02 in 2024, then surged by 90.32% to -$0.58 in 2025.
- Business Quant data shows BBLGW's EPS (Basic) at -$0.58 in Q4 2025, -$0.37 in Q3 2025, and -$1.33 in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.58 |
| Sep 30, 2025 | -0.37 |
| Jun 30, 2025 | -1.33 |
| Mar 31, 2025 | -1.92 |
| Dec 31, 2024 | -6.02 |
| Sep 30, 2024 | -14.21 |
| Jun 30, 2024 | -4.08 |
| Mar 31, 2024 | -8.20 |
| Dec 31, 2023 | -35.34 |
| Sep 30, 2023 | -29.40 |
| Jun 30, 2023 | -139.34 |
| Mar 31, 2023 | -281.37 |
| Dec 31, 2022 | -2,728.08 |
| Sep 30, 2022 | -169.65 |
| Jun 30, 2022 | -60.92 |
| Mar 31, 2022 | -95.94 |
| Dec 31, 2021 | -55.85 |
| Sep 30, 2021 | -251.88 |
| Jun 30, 2021 | -243.27 |
| Mar 31, 2021 | -213.52 |